# High Flow Therapy for the Treatment of Respiratory Failure in the ED

> **NCT02236559** · NA · COMPLETED · sponsor: **Vapotherm, Inc.** · enrollment: 204 (actual)

## Conditions studied

- Acute Respiratory Failure

## Interventions

- **DEVICE:** Noninvasive positive pressure ventilation (NIPPV)
- **DEVICE:** Vapotherm

## Key facts

- **NCT ID:** NCT02236559
- **Lead sponsor:** Vapotherm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-09
- **Final completion:** 2017-02
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2019-05-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236559, "High Flow Therapy for the Treatment of Respiratory Failure in the ED". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02236559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*